December 14, 2016 07:37 AM ESTUpdated 10:15 AM

Pfizer inks an early-stage collaboration deal as it invests in another startup; Stem cell startup lands cardiac tech

Shehla Shakoor

Managing Director

A busy Pfizer is partnering with South San Francisco-based Ab Initio Biotherapeutics on the discovery of new GPCR activator drugs. Pfizer is investing in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Pfizer inks an early-stage collaboration deal as it invests in another startup; Stem cell startup lands cardiac tech

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Patient dies in Neurogene's Rett syndrome study

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Are programs with compounded GLP-1s safe for your population?

Pfiz­er inks an ear­ly-stage col­lab­o­ra­tion deal as it in­vests in an­oth­er start­up; Stem cell start­up lands car­diac tech

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Pfizer inks an early-stage collaboration deal as it invests in another startup; Stem cell startup lands cardiac tech

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Patient dies in Neurogene's Rett syndrome study

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Are programs with compounded GLP-1s safe for your population?